Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism

通过氧传感机制调节视网膜血管生成和血管完整性

基本信息

  • 批准号:
    9752547
  • 负责人:
  • 金额:
    $ 48.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2021-01-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Angiogenesis has been mostly studied by examining stimulation (or inhibition) of endothelial cells (ECs) by extracellular ligands, with much less attention being paid to communications between ECs and their surrounding tissue environment. In this project we will focus on how the oxygen sensing mechanism coordinates astrocytic and vascular communication during retinal vascular morphogenesis and explore its therapeutic potentials in protecting retinal microvascular integrity in two models including oxygen induced retinopathy (OIR) and diabetic retinopathy. In preliminary studies we obtained concrete evidence that nascent retinal blood vessels drive retinal astrocytic progenitors (APCs) to differentiate into mature astrocytes (mASCs) and form an astrocytic network. Specifically, we hypothesize that leukemia inhibitory factor (LIF) from retinal vascular ECs and oxygen from the circulation may act on APCs to upregulate the expression and activity of prolyl hydroxylase domain protein 2 (PHD2), which in turn catalyzes prolyl hydroxylation of HIF-a proteins, tagging them for polyubiquitination and proteasomal degradation. Furthermore, we propose that HIF-2a and Tlx (a transcription factor in the orphan nuclear receptor family) may form a positive feedback loop wherein Tlx suppresses polyubiquitination and degradation of hydroxylated HIF-2a whereas HIF-2a promotes the transcription of the Tlx gene. Thus, downregulation of HIF-2a protein abundance by PHD2 might trigger a downward spiral of both HIF-2a and Tlx levels, leading to astrocyte maturation from their progenitors. On the other hand, our studies indicate that loss of PHD2 may be targeted to help preserve retinal vascular integrity in OIR or diabetes models, likely by stabilizing HIF-2a. We will investigate these issues in three specific aims. Aim 1. Determine if LIF regulates astrocyte and vascular development through oxygen sensing mechanisms. We will evaluate in vivo if LIF upregulates Phd2 expression, promotes the differentiation of APCs (proangiogenic) to mASCs (nonangiogenic), thus suppressing retinal angiogenesis. Aim 2. Investigate if a positive feedback loop between HIF-2a and Tlx promotes APC status and retinal angiogenesis. Aim 3. Explore therapeutic potentials of the oxygen sensing pathway in mouse OIR and diabetic retinopathy models. We will determine if mASC specific PHD2 deficiency, global or EC specific LIF deficiency, or LIF antagonist protects retinal microvessels from hyperoxia or diabetes-induced injuries. In summary, these studies are designed to provide mechanistic insights into vascular and astrocyte communication and reveal novel therapeutic opportunities to treat retinopathy of the prematurity and diabetic retinopathy.
 描述(由申请人提供):血管生成主要通过检查细胞外配体对内皮细胞(EC)的刺激(或抑制)来研究,很少关注EC与其周围组织环境之间的通信。本课题将重点研究氧传感机制在视网膜血管形态发生过程中如何协调星形胶质细胞和血管的通讯,并探讨其在氧诱导视网膜病变(OIR)和糖尿病视网膜病变(DR)两种模型中保护视网膜微血管完整性的治疗潜力。在初步研究中,我们获得了新生视网膜血管驱动视网膜星形胶质细胞祖细胞(APC)分化为成熟星形胶质细胞(mASC)并形成星形胶质细胞网络的具体证据。具体而言,我们假设来自视网膜血管EC的白血病抑制因子(LIF)和来自循环的氧可以作用于APC以上调脯氨酰羟化酶结构域蛋白2(PHD 2)的表达和活性,PHD 2反过来催化HIF-a蛋白的脯氨酰羟化,标记它们用于聚泛素化和蛋白酶体降解。此外,我们提出HIF-2a和Tlx(孤儿核受体家族中的转录因子)可能形成正反馈环,其中Tlx抑制多聚泛素化和羟基化HIF-2a的降解,而HIF-2a促进Tlx基因的转录。因此,PHD 2下调HIF-2a蛋白丰度可能引发HIF-2a和Tlx水平的螺旋下降,导致星形胶质细胞从其祖细胞成熟。另一方面,我们的研究表明,PHD 2的丢失可能有助于保护OIR或糖尿病模型中的视网膜血管完整性,可能是通过稳定HIF-2a。我们将从三个具体目标来研究这些问题。目标1.确定LIF是否通过氧传感机制调节星形胶质细胞和血管发育。我们将在体内评估LIF是否上调Phd 2表达,促进APC(促血管生成)分化为mASC(非血管生成),从而抑制视网膜血管生成。目标2.研究HIF-2a和Tlx之间的正反馈回路是否促进APC状态和视网膜血管生成。目标3.探讨小鼠OIR和糖尿病视网膜病变模型中氧感受通路的治疗潜力。我们将确定mASC特异性PHD 2缺陷、全局或EC特异性LIF缺陷或LIF拮抗剂是否保护视网膜微血管免受高氧或糖尿病诱导的损伤。总之,这些研究旨在为血管和星形胶质细胞通讯提供机制见解,并揭示治疗早产儿视网膜病变和糖尿病视网膜病变的新治疗机会。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis.
  • DOI:
    10.1038/nm.4035
  • 发表时间:
    2016-02
  • 期刊:
  • 影响因子:
    82.9
  • 作者:
    Cao Z;Lis R;Ginsberg M;Chavez D;Shido K;Rabbany SY;Fong GH;Sakmar TP;Rafii S;Ding BS
  • 通讯作者:
    Ding BS
Vasculogenesis and Angiogenesis in VEGF Receptor-1 Deficient Mice.
Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.
  • DOI:
    10.1084/jem.20171012
  • 发表时间:
    2018-02-05
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seki T;Hosaka K;Fischer C;Lim S;Andersson P;Abe M;Iwamoto H;Gao Y;Wang X;Fong GH;Cao Y
  • 通讯作者:
    Cao Y
Improved vascular survival and growth in the mouse model of hindlimb ischemia by a remote signaling mechanism.
  • DOI:
    10.1016/j.ajpath.2013.11.032
  • 发表时间:
    2014-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Takeda;L. Duan;Hiromi Takeda;G. Fong
  • 通讯作者:
    K. Takeda;L. Duan;Hiromi Takeda;G. Fong
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis.
  • DOI:
    10.1158/0008-5472.can-13-0566
  • 发表时间:
    2013-08-01
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Criscimanna A;Duan LJ;Rhodes JA;Fendrich V;Wickline E;Hartman DJ;Monga SP;Lotze MT;Gittes GK;Fong GH;Esni F
  • 通讯作者:
    Esni F
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Guo-Hua Fong其他文献

Guo-Hua Fong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Guo-Hua Fong', 18)}}的其他基金

The Oxygen Sensing Mechanism in Retinal Endothelial Cells as a Novel Target to Suppress Ischemic Neovascularization
视网膜内皮细胞的氧传感机制作为抑制缺血性新生血管的新靶点
  • 批准号:
    10653006
  • 财政年份:
    2020
  • 资助金额:
    $ 48.71万
  • 项目类别:
The Oxygen Sensing Mechanism in Retinal Endothelial Cells as a Novel Target to Suppress Ischemic Neovascularization
视网膜内皮细胞的氧传感机制作为抑制缺血性新生血管的新靶点
  • 批准号:
    10436853
  • 财政年份:
    2020
  • 资助金额:
    $ 48.71万
  • 项目类别:
Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
  • 批准号:
    8111842
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
  • 批准号:
    7903883
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
  • 批准号:
    8301727
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
  • 批准号:
    7699482
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
Spatial cues for retinal angiogenesis
视网膜血管生成的空间线索
  • 批准号:
    8518334
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
Regulation of retinal angiogenesis and vascular integrity by the oxygen sensing mechanism
通过氧传感机制调节视网膜血管生成和血管完整性
  • 批准号:
    8964228
  • 财政年份:
    2009
  • 资助金额:
    $ 48.71万
  • 项目类别:
A novel technology to generate conditionally inactivated alleles in mice
一种在小鼠体内产生条件失活等位基因的新技术
  • 批准号:
    7315988
  • 财政年份:
    2007
  • 资助金额:
    $ 48.71万
  • 项目类别:
A novel technology to generate conditionally inactivated alleles in mice
一种在小鼠体内产生条件失活等位基因的新技术
  • 批准号:
    7471453
  • 财政年份:
    2007
  • 资助金额:
    $ 48.71万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 48.71万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 48.71万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 48.71万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 48.71万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 48.71万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了